Document Detail

Role of oxidative stress in hypoxia preconditioning of cells transplanted to the myocardium: a molecular imaging study.
MedLine Citation:
PMID:  21792164     Owner:  NLM     Status:  MEDLINE    
AIM: Cell-based therapies are a potential therapeutic alternative for the treatment of coronary artery disease (CAD). However, transplanted cells undergo significant death in the living subject. Hypoxic preconditioning (HPC) is a potential intervention to increase transplanted cell survival. However, the biological mechanisms of this benefit remain unclear. We hypothesize that the beneficial effect of HPC on stem cell survival is in part due to preservation of oxidant status, an effect that will be monitored using state-of-the-art molecular imaging.
METHODS: H9c2 rat cardiomyoblasts expressing the construct CMV-firefly luciferase (h9c2-fluc), with and without HPC, were exposed to hypoxia, and oxidative stress and cell survival were measured. Subsequently, H9c2-fluc cells, with and without HPC, were injected into the myocardium of rats and cell survival was monitored daily with Bioluminescence (BLI) using a CCD camera.
RESULTS: Compared to controls, cells exposed to hypoxia had increased amount of reactive oxygen species (ROS, control: 14.1±0.9 vs. hypoxia: 19.5 ± 2.0 RFU/µg protein, P=0.02) and decreased cell survival (control: 0.29 ± 0.005 vs. hypoxia: 0.24 ± 0.005 OD, P<0.001). HPC treatment decreased the amount of hypoxia-induced ROS (HPC: 11.5 ± 0.7RFU/µg protein, P=0.002 vs. hypoxia and P=0.11 vs. control), associated with improved survival (HPC: 0.27 ± 0.004OD/µg protein, P=0.002 vs. hypoxia and P=0.005 vs. control). Most importantly, compared to un-conditioned cells, HPC-cells had increased cell survival after transplantation to the myocardium (C: 34.7 ± 6.7% vs. HPC: 83.4 ± 17.5% at day 5 compared to day 1, P=0.01).
CONCLUSION: The beneficial effect of HPC is in part due to preservation of oxidant status. Molecular imaging can assess changes in cell survival in the living subject and has the potential to be applied clinically.
A Aly; K Peterson; A Lerman; L Lerman; M Rodriguez-Porcel
Related Documents :
1674864 - Presence of histamine h2-receptors on human gastric carcinoma cell line mkn-45 and thei...
2548614 - The effects of p21n-ras expression in nih-3t3 cells upon cyclic amp metabolism.
6162004 - Properties of bovine oligodendroglia isolated by a new procedure using physiologic cond...
190234 - Regulation of cyclic nucleotide phosphodiesterases in cultured hepatoma cells by dexame...
21571074 - Automation of large scale transient protein expression in mammalian cells.
10699984 - Downregulation of lar tyrosine phosphatase prevents apoptosis and augments ngf-induced ...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of cardiovascular surgery     Volume:  52     ISSN:  0021-9509     ISO Abbreviation:  J Cardiovasc Surg (Torino)     Publication Date:  2011 Aug 
Date Detail:
Created Date:  2011-07-27     Completed Date:  2011-11-15     Revised Date:  2014-09-09    
Medline Journal Info:
Nlm Unique ID:  0066127     Medline TA:  J Cardiovasc Surg (Torino)     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  579-85     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Hypoxia
Cell Line
Cell Survival
Cell Tracking* / methods
Cytomegalovirus / genetics
Genes, Reporter
Luciferases, Firefly / biosynthesis,  genetics
Luminescent Measurements
Myocardium / metabolism*,  pathology
Myocytes, Cardiac / metabolism,  pathology,  transplantation*
Oxidative Stress*
Rats, Sprague-Dawley
Reactive Oxygen Species / metabolism*
Time Factors
Grant Support
Reg. No./Substance:
0/Reactive Oxygen Species; EC, Firefly

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Visceral artery aneurysms: management of 48 cases.
Next Document:  Quality of life one year post myocardial revascularization and aortic valve replacement in patients ...